Description:

TF: Radiation Therapy Oncology Group Phase III Esophagus Systemic Treatment Summary Form Paclitaxel, Cisplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Locally Advanced Esophageal Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=2A02FE34-6EF5-5B5C-E044-0003BA3F9857

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=2A02FE34-6EF5-5B5C-E044-0003BA3F9857

Keywords:
Versions (5) ▾
  1. 9/19/12
  2. 1/9/15
  3. 1/9/15
  4. 1/29/19
  5. 9/27/21
Copyright Holder:
NCI
Uploaded on:

September 27, 2021

DOI:
No DOI assigned. To request one please log in.
License:
Creative Commons BY-NC 3.0
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Esophageal Cancer NCT00655876 Treatment - TF: Radiation Therapy Oncology Group Phase III Esophagus Systemic Treatment Summary Form - 2598533v1.0

No Instruction available.

  1. StudyEvent: TF: Radiation Therapy Oncology Group Phase III Esophagus Systemic Treatment Summary Form
    1. No Instruction available.
Module 1
AMENDED DATA
Patient Characteristics
cm
Kg
Was dose modified due to weight loss
Day the dose was modified
Unnamed Module 1
Units
Were there any dose modifications or additions/omissions to protocol treatment?
Reason Treatment Ended
Report All Continuing Or New Adverse Events
CTC AE Term
CTC Adverse Event Attribution (Attribution to Protocol Treatment See protocol sections 6 & 7 for definition of "protocol treatment")
Has an AdEERS been filed
Was this SAE per NCI definitions
Is there a reasonable possibility that the event may have been caused by the investigational agent
Action taken regarding study therapy
Treatment required
Present Status
Report All Continuing Or New Adverse Events
New or continuing adverse events
CTC AE Term
CTC Adverse Event Attribution (Attribution to Protocol Treatment See protocol sections 6 & 7 for definition of "protocol treatment")
Has an AdEERS been filed
Was this SAE per NCI definitions
Is there a reasonable possibility that the event may have been caused by the investigational agent
Action taken regarding study therapy
Treatment required
Present Status
Footer

Similar models